256 top medical experts on Pseudohypoaldosteronism across 28 countries and 21 U.S. states, including 81 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Pseudohypoaldosteronism: A heterogeneous group of disorders characterized by renal electrolyte transport dysfunctions. Congenital forms are rare autosomal disorders characterized by neonatal hypertension, hyperkalemia, increased renin activity and aldosterone concentration. The Type I features hyperkalemia with sodium wasting; Type II, hyperkalemia without sodium wasting. Pseudohypoaldosteronism can be the result of a defective renal electrolyte transport protein or acquired after kidney transplantation.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Inborn Errors Renal Tubular Transport (984).
  4. Clinical Trials ClinicalTrials.gov : at least 4 including 4 Completed
  5. Synonyms: Gordon Hyperkalemia-Hypertension Syndrome,  Familial Hyperpotassemia and Hypertension,  Familial Hypertensive Hyperkalemia,  Pseudohypoaldosteronism Type 1,  Autosomal Recessive Pseudohypoaldosteronism Type 1,  Type I Pseudohypoaldosteronism,  Autosomal Dominant Type I Pseudohypoaldosteronism,  Autosomal Recessive Type I Pseudohypoaldosteronism,  Type II Pseudohypoaldosteronism


  

        

                    


    Computing Expert Listing ...

);